The FDA has approved Plenvu (NER1006), from Norgine + Salix, an osmotic laxative indicated for cleansing of the colon in...
The approval was granted under the European decentralised procedure, with the UK as reference state. Plenvu has also been approved in Australia.
Norgine presented new data demonstrating the superior high-quality bowel cleansing efficacy (in at least one segment of the colon) of...
Norgine B.V. announced new data showing that there is a strong correlation between higher cleansing scores and increased polyp detection...
Background: Polyethylene glycol (PEG)-based bowel preparations are effective cleansers but many require high-volume intake.
Norgine B.V. announced that it has received acceptance from the FDA for the New Drug Application (NDA) for PLENVU (NER...
Norgine B.V.has announced positive new Plenvu (NER1006) superiority data at the meeting of the Belgian Society for Gastrointestinal Endoscopy (BSGIE)....
Salix Pharmaceuticals, Ltd ,a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., and its partner Norgine B.V. have received notice...
Norgine announced that results from the Plenvu (polyethylene glycol based bowel preparation) Phase III MORA trial were published in ENDOSCOPY,...
Norgine announced positive top line results for its phase III study, NOCT, a multicentre, randomised, parallel-group clinical trial comparing the...